SEC Tracker
Get the app
HYPR · XBRL financial data

Hyperfine financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (HYPR's year ends in late December)

In thousands of dollarsDec 31, 2021†Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue from contracts with customers1,4966,81411,03212,89013,563
Cost of goods and services sold2,6635,9076,2756,9996,810
Gross profit(1,167)9074,7575,8916,753
Research and development25,84228,15622,49322,49917,451
General and administrative27,49732,40620,27617,49416,253
Total operating expenses63,70174,78152,87249,11543,838
Operating income (loss)(64,868)(73,874)(48,115)(43,224)(37,085)
Interest income187613,8422,4921,023
Other income (expense)(1)(51)3512(337)
Income tax expense (benefit)00000
Net income (loss)(64,851)(73,164)(44,238)(40,720)(35,574)
Earnings per share, basic USD per share(17.57)(1.04)(0.62)(0.56)(0.43)
Earnings per share, diluted USD per share(17.57)(1.04)(0.62)(0.56)(0.43)
Weighted average shares, basic thousands of shares3,69170,44971,31672,41481,795
Weighted average shares, diluted thousands of shares3,69170,44971,31672,41481,795
  • † Share count changed about 19x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (HYPR's year ends in late December)

In thousands of dollarsDec 31, 2021†Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents188,498117,47275,18337,64535,085
Accounts receivable5532,1033,1895,9565,254
Inventory4,3104,6226,5825,8327,090
Prepaid and other current assets1,3573,1942,3911,9001,255
Total current assets197,485128,66488,90853,71050,909
Property and equipment, net3,7533,2482,9993,1222,549
Right-of-use asset——239341316
Total assets202,473134,05194,19958,90155,262
Accounts payable2,2486781,2141,6074,051
Total current liabilities15,7368,8038,7688,72911,732
Long-term debt————0
Lease liability, non-current——647866
Total liabilities16,24610,3299,8009,86114,257
Accumulated deficit(136,320)(209,484)(253,722)(294,442)(330,016)
Total stockholders' equity186,227123,72284,39949,04041,005
Total liabilities and equity202,473134,05194,19958,90155,262
  • † Share count changed about 19x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (HYPR's year ends in late December)

In thousands of dollarsDec 31, 2021†Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)(64,851)(73,164)(44,238)(40,720)(35,574)
Stock-based compensation6,90110,6524,7414,3622,801
Depreciation and amortization7261,015———
Net cash from operating activities(47,182)(72,339)(41,809)(38,767)(27,948)
Purchases of property and equipment2,7115858043831,185
Net cash from investing activities(2,711)(585)(804)(383)(1,185)
Net cash from financing activities176,76771741,01927,502
  • † Share count changed about 19x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Hyperfine43,4583,904(7,268)*not reported6.0 quarters 10-QJun 30, 2026
Xtant Medical Holdings9,87023,031(7,308)*140.3M1.4 quarters 10-QJun 30, 2026
Vivani Medical19,894not reported(6,035)*90.2M3.3 quarters 10-QJun 30, 2026
Alpha Pro Tech18,901not reported2,213*10.2M— 10-QJun 30, 2026
CapsoVisionnot reported3,643(8,403)*50.0M— 10-QJun 30, 2026
Nuo Therapeutics449not reported(236)*48.4M1.9 quarters 10-QJun 30, 2026
Vivos2,33636(740)*494.2M3.2 quarters 10-QJun 30, 2026
Milestone Scientific2,067not reported(585)*88.7M3.5 quarters 10-QJun 30, 2026
Fractyl Health47,140not reported(15,901)*159.2M3.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.